Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 4375253, 8 pages
https://doi.org/10.1155/2017/4375253
Research Article

Association between Sex Hormone and Blood Uric Acid in Male Patients with Type 2 Diabetes

1The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210013, China
2Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China

Correspondence should be addressed to Chao Liu

Received 6 June 2017; Revised 4 September 2017; Accepted 14 September 2017; Published 3 October 2017

Academic Editor: Mario Maggi

Copyright © 2017 Wen Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. K. Kim, J. Cheon, K. S. Lee et al., “An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia,” International Journal of Clinical Practice, vol. 64, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Wang, E. Nieschlag, R. Swerdloff et al., “Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations,” Journal of Andrology, vol. 30, pp. 1–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. H. Jones, “Effects of testosterone on type 2 diabetes and components of the metabolic syndrome,” Journal of Diabetes, vol. 2, pp. 146–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Corona, E. Mannucci, L. Petrone et al., “Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic,” International Journal of Impotence Research, vol. 18, pp. 190–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Corona, L. Vignozzi, A. Sforza, E. Mannucci, and M. Maggi, “Obesity and late-onset hypogonadism,” Molecular and Cellular Endocrinology, vol. 418, Part 2, pp. 120–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Brand, M. M. Rovers, B. B. Yeap et al., “Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies,” PLoS One, vol. 9, article e100409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Borghi, E. A. Rosei, T. Bardin et al., “Serum uric acid and the risk of cardiovascular and renal disease,” Journal of Hypertension, vol. 33, pp. 1729–1741, 2015, discussion 1741. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Chen, S. Y. Chuang, H. J. Chen, W. T. Yeh, and W. H. Pan, “Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study,” Arthritis and Rheumatism, vol. 61, pp. 225–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Al Hayek, Y. S. Khader, S. Jafal, N. Khawaja, A. A. Robert, and K. Ajlouni, “Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study,” Journal of Family & Community Medicine, vol. 20, pp. 179–186, 2013. View at Publisher · View at Google Scholar
  10. M. Grossmann, “Low testosterone in men with type 2 diabetes: significance and treatment,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, pp. 2341–2353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. G. Cohen, “The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt—a major factor in the genesis of morbid obesity,” Medical Hypotheses, vol. 52, pp. 49–51, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Corona, V. A. Giagulli, E. Maseroli et al., “Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study,” European Journal of Endocrinology, vol. 174, no. 3, pp. R99–R116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Corona, V. A. Giagulli, E. Maseroli et al., “Testosterone supplementation and body composition: results from a meta-analysis of observational studies,” Journal of Endocrinological Investigation, vol. 39, pp. 967–981, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Y. Ma, C. Y. Yang, S. R. Shih et al., “Measurement of waist circumference: midabdominal or iliac crest?” Diabetes Care, vol. 36, pp. 1660–1666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. I. Feig, M. Madero, D. I. Jalal, L. G. Sanchez-Lozada, and R. J. Johnson, “Uric acid and the origins of hypertension,” The Journal of Pediatrics, vol. 162, pp. 896–902, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Rodrigues, M. P. Baldo, P. Capingana et al., “Gender distribution of serum uric acid and cardiovascular risk factors: population based study,” Arquivos Brasileiros de Cardiologia, vol. 98, pp. 13–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Nakamura, M. Sakurai, K. Miura et al., “Serum gamma-glutamyltransferase and the risk of hyperuricemia: a 6-year prospective study in Japanese men,” Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, vol. 44, pp. 966–974, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Yu, H. Yang, X. Guo et al., “Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities,” Clinical Rheumatology, vol. 35, pp. 1207–1215, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. A. F. Neto, M. A. de Freitas Rodrigues, J. A. Saraiva Fittipaldi, and E. D. Moreira Jr., “The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil,” International Journal of Impotence Research, vol. 14, Supplement 2, pp. S19–S26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. YenicerioGlu, A. Kefi, G. Aslan et al., “Efficacy and safety of sildenafil for treating erectile dysfunction in patients on dialysis,” BJU International, vol. 90, pp. 442–445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Esen, S. Kahvecioglu, A. E. Atay et al., “Evaluation of relationship between sexual functions, depression and quality of life in patients with chronic kidney disease at predialysis stage,” Renal Failure, vol. 37, pp. 262–267, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Peter, K. Kantartzis, J. Machann et al., “Relationships of circulating sex hormone-binding globulin with metabolic traits in humans,” Diabetes, vol. 59, pp. 3167–3173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. K. Stamp, J. E. Wells, S. Pitama et al., “Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities,” Internal Medicine Journal, vol. 43, pp. 678–684, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. M. Hurina, O. V. Korpacheva-Zinych, and A. A. Shuprovych, “Interrelations of uric acid metabolism indices with insulin and testosterone levels in men with type 2 diabetes,” Fiziolohichnyĭ Zhurnal, vol. 56, pp. 93–99, 2010. View at Google Scholar
  25. J. H. Lim, Y. K. Kim, Y. S. Kim, S. H. Na, M. Y. Rhee, and M. M. Lee, “Relationship between serum uric acid levels, metabolic syndrome, and arterial stiffness in Korean,” Korean Circulation Journal, vol. 40, pp. 314–320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Yialamas, A. A. Dwyer, E. Hanley, H. Lee, N. Pitteloud, and F. J. Hayes, “Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, pp. 4254–4259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Afsar and H. Karaca, “The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis,” Central European Journal of Urology, vol. 67, pp. 58–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. I. V. Mukhin, G. A. Ignatenko, and V. Y. Nikolenko, “Dyshormonal disorders in gout: experimental and clinical studies,” Bulletin of Experimental Biology and Medicine, vol. 133, pp. 491–493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Tong, X. Hua, Y. Zhong et al., “Intensive insulin therapy increases sex hormone-binding globulin in newly diagnosed type 2 diabetic patients,” European Journal of Endocrinology, vol. 170, pp. 237–245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Wang, R. P. Chen, L. Lei et al., “Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China,” Asia Pacific Journal of Clinical Nutrition, vol. 22, pp. 590–598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Cordain, M. R. Eades, and M. D. Eades, “Hyperinsulinemic diseases of civilization: more than just syndrome X,” Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 136, pp. 95–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Stockl, A. Doring, B. Thorand, M. Heier, P. Belcredi, and C. Meisinger, “Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 study,” PLoS One, vol. 7, article e32668, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Maninger, O. M. Wolkowitz, V. I. Reus, E. S. Epel, and S. H. Mellon, “Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS),” Frontiers in Neuroendocrinology, vol. 30, pp. 65–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Fischli, S. Jenni, S. Allemann et al., “Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, pp. 539–542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. P. Nasrallah and B. M. Arafah, “The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, pp. 5293–5298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. B. M. Kudielka and S. Wust, “Human models in acute and chronic stress: assessing determinants of individual hypothalamus-pituitary-adrenal axis activity and reactivity,” Stress, vol. 13, pp. 1–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Sumino, S. Ichikawa, T. Kanda, T. Nakamura, and T. Sakamaki, “Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia,” Lancet, vol. 354, p. 650, 1999. View at Publisher · View at Google Scholar
  38. R. Yahyaoui, I. Esteva, J. J. Haro-Mora et al., “Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, pp. 2230–2233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Pui, C. Waddell, and N. Dalbeth, “Early onset of hyperuricaemia and gout following treatment for female to male gender reassignment,” Rheumatology, vol. 47, pp. 1840-1841, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Bosello and M. Zamboni, “Visceral obesity and metabolic syndrome,” Obesity Reviews: an Official Journal of the International Association for the Study of Obesity, vol. 1, pp. 47–56, 2000. View at Publisher · View at Google Scholar
  41. M. A. Lanaspa, L. G. Sanchez-Lozada, C. Cicerchi et al., “Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver,” PLoS One, vol. 7, article e47948, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. P. Cruz-Dominguez, D. H. Cortes, A. Zarate et al., “Relationship of ghrelin, acid uric and proinflammatory adipocytokines in different degrees of obesity or diabetes,” International Journal of Clinical and Experimental Medicine, vol. 7, pp. 1435–1441, 2014. View at Google Scholar
  43. C. A. Christian and S. M. Moenter, “The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges,” Endocrine Reviews, vol. 31, pp. 544–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. S. Levey, L. A. Stevens, C. H. Schmid et al., “A new equation to estimate glomerular filtration rate,” Annals of Internal Medicine, vol. 150, pp. 604–612, 2009. View at Google Scholar
  45. S. Zharikov, K. Krotova, H. Hu et al., “Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells,” American Journal of Physiology Cell Physiology, vol. 295, pp. C1183–C1190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Kuczera, M. Adamczak, and A. Wiecek, “Endocrine abnormalities in patients with chronic kidney disease,” Prilozi, vol. 36, pp. 109–118, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Antonucci, G. Palermo, S. M. Recupero et al., “Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients,” Archivio Italiano di Urologia, Andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, vol. 87, pp. 299–305, 2016. View at Publisher · View at Google Scholar · View at Scopus